Beverly Hills, CALIFORNIA2 Active Studies

Chronic Kidney Disease Clinical Trials in Beverly Hills, CALIFORNIA

Find 2 actively recruiting chronic kidney disease clinical trials in Beverly Hills, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
1
Sponsors
7,500
Enrolling

Recruiting Chronic Kidney Disease Studies in Beverly Hills

About Chronic Kidney Disease Clinical Trials in Beverly Hills

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 2 chronic kidney disease clinical trials recruiting participants in Beverly Hills, CALIFORNIA. These studies are seeking a combined 7,500 participants. Research is being sponsored by AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in Beverly Hills — FAQ

Are there chronic kidney disease clinical trials in Beverly Hills?

Yes, there are 2 chronic kidney disease clinical trials currently recruiting in Beverly Hills, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Beverly Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beverly Hills research site will contact you about next steps.

Are clinical trials in Beverly Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beverly Hills studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 2 active trials in Beverly Hills are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated March 2, 2026 from ClinicalTrials.gov